425
Views
5
CrossRef citations to date
0
Altmetric
COMMENTARY

Sidney Farber and the Treatment of Childhood Acute Lymphoblastic Leukemia with a Chemotherapeutic Agent

Pages 299-302 | Received 17 Mar 2012, Accepted 20 Mar 2012, Published online: 08 May 2012

REFERENCES

  • Infield GB. Disaster at Bari. New York: Macmillan; 1971.
  • Goodman LS, Wintrobe MM, Dameshek W, Use of methyl-bis (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia. JAMA. 1946;132:126–136.
  • Jacobson LP, Spurr C, Barron E, Studies of the effect of methyl-bis (beta-chloroethyl) amine hydrochloride on neoplastic diseases and allied disorders of hematopoietic system. JAMA. 1946;132:236–252.
  • Virchow R. Weisses blut. Frorieps Notitzen. 1845;36:151.
  • Bennett J. Case of hypertrophy of the spleen and liver in which death took place from suppuration of blood. Edinb Med Surg J. 1845;64:413–423.
  • Hutchings BL, Mowat JH, Oleson JJ, Pteroylaspartic acid, an antagonist for pteroylglutamic acid. J Biol Chem. 1947;170:323–328.
  • Farber S, Diamond LK, Mercer RD, Temporary remission in acute leukemia in children produced by folic acid antagonist, 4 amino pteroylglutamic acid (aminopterin). N Engl J Med. 1948;238:787–793.
  • Farber S. Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer. Blood. 1949;4:160–167.
  • Goldin A, Mantel N, Greenhouse SW, Factors influencing the specificity of action of an antileukemic agent (aminopterin): time of treatment and dosage schedule. Cancer Res. 1954;14:311–314.
  • Niemayer CM, Hitchcock-Bryan S, Sallon SE. Comparative analysis of treatment programs for childhood acute lymphoblastic leukemia. Semin Oncol. 1985;12:122–130.
  • Holland JF, Glidewell O. Chemotherapy of acute lymphocytic leukemia in childhood. Cancer. 1972;30:1480–1487.
  • Miller LP, Miller DR. Acute lymphoblastic leukemia in children: current status, controversies, and future perspectives. CRR Crit Rev Oncol. 1985;1:129–196.
  • Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med. 1998;339:605.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.